These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1675620)

  • 1. The effects of sulfasalazine metabolites on hemoglobin-catalyzed lipid peroxidation.
    Yamada T; Volkmer C; Grisham MB
    Free Radic Biol Med; 1991; 10(1):41-9. PubMed ID: 1675620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free radical scavenging reactions of sulfasalazine, 5-aminosalicylic acid and sulfapyridine: mechanistic aspects and antioxidant activity.
    Joshi R; Kumar S; Unnikrishnan M; Mukherjee T
    Free Radic Res; 2005 Nov; 39(11):1163-72. PubMed ID: 16298742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of BX661A, a new therapeutic agent for ulcerative colitis, on reactive oxygen species in comparison with salazosulfapyridine and its metabolite sulfapyridine.
    Kimura I; Kumamoto T; Matsuda A; Kataoka M; Kokuba Y
    Arzneimittelforschung; 1998 Oct; 48(10):1007-11. PubMed ID: 9825118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 5-aminosalicylic acid and analogous substances on superoxide generation and intracellular free calcium in human neutrophilic granulocytes.
    Nielsen OH; Bouchelouche PN; Berild D; Ahnfelt-Rønne I
    Scand J Gastroenterol; 1993 Jun; 28(6):527-32. PubMed ID: 8100641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of aminosalicylates and immunosuppressive agents on nitric oxide-dependent N-nitrosation reactions.
    Grisham MB; Miles AM
    Biochem Pharmacol; 1994 May; 47(10):1897-902. PubMed ID: 8204107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scavenger effect of sulfasalazine, 5-aminosalicylic acid, and olsalazine on superoxide radical generation.
    Gionchetti P; Guarnieri C; Campieri M; Belluzzi A; Brignola C; Iannone P; Miglioli M; Barbara L
    Dig Dis Sci; 1991 Feb; 36(2):174-8. PubMed ID: 1671010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of red cell membrane lipid peroxidation by sulphasalazine and 5-aminosalicylic acid.
    Greenfield SM; Punchard NA; Thompson RP
    Gut; 1991 Oct; 32(10):1156-9. PubMed ID: 1683330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfasalazine metabolites and dapsone attenuate formyl-methionyl-leucyl-phenylalanine-induced mucosal injury in rat ileum.
    von Ritter C; Grisham MB; Granger DN
    Gastroenterology; 1989 Mar; 96(3):811-6. PubMed ID: 2563347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrogen peroxide-induced oxidative stress to the mammalian heart-muscle cell (cardiomyocyte): lethal peroxidative membrane injury.
    Janero DR; Hreniuk D; Sharif HM
    J Cell Physiol; 1991 Dec; 149(3):347-64. PubMed ID: 1744169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of aminosalicylic acid derivatives on nitric oxide in a cell-free system.
    Reynolds PD; Middleton SJ; Shorthouse M; Hunter JO
    Aliment Pharmacol Ther; 1995 Oct; 9(5):491-5. PubMed ID: 8580268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfasalazine and 5-aminosalicylic acid inhibit contractile leukotriene formation.
    Nielsen ST; Beninati L; Buonato CB
    Scand J Gastroenterol; 1988 Apr; 23(3):272-6. PubMed ID: 2898806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evidence supporting the radical scavenger mechanism of 5-aminosalicylic acid.
    Ahnfelt-Rønne I; Nielsen OH; Christensen A; Langholz E; Binder V; Riis P
    Gastroenterology; 1990 May; 98(5 Pt 1):1162-9. PubMed ID: 1969825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actions of sulfasalazine and 5-aminosalicylic acid as reactive oxygen scavengers in the suppression of bile acid-induced increases in colonic epithelial cell loss and proliferative activity.
    Craven PA; Pfanstiel J; Saito R; DeRubertis FR
    Gastroenterology; 1987 Jun; 92(6):1998-2008. PubMed ID: 2883067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of neutrophil degranulation and superoxide production by sulfasalazine. Comparison with 5-aminosalicylic acid, sulfapyridine and olsalazine.
    Neal TM; Winterbourn CC; Vissers MC
    Biochem Pharmacol; 1987 Sep; 36(17):2765-8. PubMed ID: 2888463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of intestinal macrophage chemotaxis to leukotriene B4 by sulphasalazine, olsalazine, and 5-aminosalicylic acid.
    Nielsen OH; Verspaget HW; Elmgreen J
    Aliment Pharmacol Ther; 1988 Jun; 2(3):203-11. PubMed ID: 2908754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced formation of sulfidopeptide-leukotrienes in ulcerative colitis and Crohn's disease: inhibition by sulfasalazine and 5-aminosalicylic acid.
    Peskar BM; Dreyling KW; Peskar BA; May B; Goebell H
    Agents Actions; 1986 Jun; 18(3-4):381-3. PubMed ID: 2875632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of mesalazine, an agent for the treatment of idiopathic inflammatory bowel disease, on reactive oxygen metabolites and LTB4 formation].
    Nakamaru K; Sugai T; Kinoshita N; Sato M; Taniguchi S; Kawase S
    Nihon Yakurigaku Zasshi; 1994 Dec; 104(6):447-57. PubMed ID: 7851818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of the in vitro prosecretory effects of balsalazide, sulfasalazine, olsalazine, and mesalamine in rabbit distal ileum.
    Kles KA; Vavricka SR; Turner JR; Musch MW; Hanauer SB; Chang EB
    Inflamm Bowel Dis; 2005 Mar; 11(3):253-7. PubMed ID: 15735431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antiinflammatory moiety of sulfasalazine, 5-aminosalicylic acid, is a radical scavenger.
    Ahnfelt-Rønne I; Nielsen OH
    Agents Actions; 1987 Jun; 21(1-2):191-4. PubMed ID: 2888280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of BX661A, a new therapeutic agent for ulcerative colitis, on chemotaxis and reactive oxygen species production in polymorphonuclear leukocytes in comparison with salazosulfapyridine and its metabolite sulfapyridine.
    Kimura I; Kawasaki M; Matsuda A; Kataoka M; Kokurba Y
    Arzneimittelforschung; 1998 Dec; 48(12):1163-7. PubMed ID: 9893931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.